Fluid Therapy and Acute Respiratory Distress Syndrome

[1]  M. Churpek,et al.  Machine Learning Classifier Models Can Identify ARDS Phenotypes Using Readily Available Clinical Data. , 2020, American journal of respiratory and critical care medicine.

[2]  K. Delucchi,et al.  Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials. , 2020, The Lancet. Respiratory medicine.

[3]  Gavin D Perkins,et al.  Guidelines on the management of acute respiratory distress syndrome , 2019, BMJ Open Respiratory Research.

[4]  A. Randolph,et al.  The acute respiratory distress syndrome. , 1996, New England Journal of Medicine.

[5]  M. Matthay,et al.  Pathogenesis of Acute Respiratory Distress Syndrome , 2019, Seminars in Respiratory and Critical Care Medicine.

[6]  J. Christie,et al.  Acute Respiratory Distress Syndrome Phenotypes , 2019, Seminars in Respiratory and Critical Care Medicine.

[7]  R. Rossaint,et al.  The acute respiratory distress syndrome: pathophysiology, current clinical practice, and emerging therapies , 2018, Expert review of respiratory medicine.

[8]  Kevin L. Delucchi,et al.  Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study , 2018, Intensive Care Medicine.

[9]  J. Major,et al.  National incidence rates for Acute Respiratory Distress Syndrome (ARDS) and ARDS cause‐specific factors in the United States (2006–2014)☆ , 2018, Journal of critical care.

[10]  Rinaldo Bellomo,et al.  Liberal Versus Restrictive Intravenous Fluid Therapy for Early Septic Shock: Rationale for a Randomized Trial. , 2018, Annals of emergency medicine.

[11]  J. Laffey,et al.  Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. , 2018, The Lancet. Respiratory medicine.

[12]  M. Matthay,et al.  Endothelial biomarkers in human sepsis: pathogenesis and prognosis for ARDS , 2018, Pulmonary circulation.

[13]  M. Egi,et al.  The clinical practice guideline for the management of ARDS in Japan , 2017, Journal of Intensive Care.

[14]  M. Matthay,et al.  Clinical trials in acute respiratory distress syndrome: challenges and opportunities. , 2017, The Lancet. Respiratory medicine.

[15]  T. van der Poll,et al.  Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis , 2017, Thorax.

[16]  V. Janout,et al.  Past and Present ARDS Mortality Rates: A Systematic Review , 2017, Respiratory Care.

[17]  K. Famous,et al.  Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy , 2016, American journal of respiratory and critical care medicine.

[18]  Anne Molgaard Nielsen,et al.  Latent Class Analysis in health research. , 2017, Journal of physiotherapy.

[19]  S. Mehta,et al.  Official Executive Summary of an American Thoracic Society/American College of Chest Physicians Clinical Practice Guideline: Liberation from Mechanical Ventilation in Critically Ill Adults , 2017, American journal of respiratory and critical care medicine.

[20]  J. Marshall,et al.  Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis , 2017, Intensive Care Medicine.

[21]  M. Balaan,et al.  Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.

[22]  Jesús Blanco,et al.  Current incidence and outcome of the acute respiratory distress syndrome , 2016, Current opinion in critical care.

[23]  James F Burke,et al.  Implications of Heterogeneity of Treatment Effect for Reporting and Analysis of Randomized Trials in Critical Care. , 2015, American journal of respiratory and critical care medicine.

[24]  Zhongheng Zhang,et al.  Effectiveness of treatment based on PiCCO parameters in critically ill patients with septic shock and/or acute respiratory distress syndrome: a randomized controlled trial , 2015, Intensive Care Medicine.

[25]  B. Spellberg,et al.  Volume of fluids administered during resuscitation for severe sepsis and septic shock and the development of the acute respiratory distress syndrome. , 2014, Journal of critical care.

[26]  Kevin Delucchi,et al.  Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. , 2014, The Lancet. Respiratory medicine.

[27]  Pae C. Wu,et al.  Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine , 2014, Critical reviews in biotechnology.

[28]  J. Marshall.  Why have clinical trials in sepsis failed? , 2014, Trends in molecular medicine.

[29]  Wei-hang Hu,et al.  Extravascular lung water and pulmonary arterial wedge pressure for fluid management in patients with acute respiratory distress syndrome , 2014, Multidisciplinary Respiratory Medicine.

[30]  M. Malinchoc,et al.  The Role of Potentially Preventable Hospital Exposures in the Development of Acute Respiratory Distress Syndrome: A Population-Based Study* , 2014, Critical care medicine.

[31]  L. Wang.  Effect of different liquid management strategies on the prognosis of acute respiratory distress syndrome , 2014 .

[32]  S. Jaber,et al.  Prone positioning in severe acute respiratory distress syndrome. , 2013, The New England journal of medicine.

[33]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[34]  M. Saeed,et al.  Risk factors for ARDS in patients receiving mechanical ventilation for > 48 h. , 2008, Chest.

[35]  M. Revel,et al.  Comparison of two fluid-management strategies in acute lung injury, H.P. Wiedemann, A.P. Wheeler, G.R. Bernard, B.T. Thompson, D. Hayden, B. deBoisblanc, A.F Jr. Connors, R.D. Hite, A.L. Harabin, in: N Engl J Med, 354. (2006), 2564 , 2007 .

[36]  R. Schwendener,et al.  Alveolar macrophages contribute to alveolar barrier dysfunction in ventilator-induced lung injury. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[37]  Gordon R Bernard,et al.  Comparison of two fluid-management strategies in acute lung injury. , 2006, The New England journal of medicine.

[38]  A. Eden.  Higher Versus Lower Positive End-Expiratory Pressures in Patients With the Acute Respiratory Distress Syndrome , 2005 .

[39]  G. Bernard,et al.  A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury* , 2005, Critical care medicine.

[40]  Marek Ancukiewicz,et al.  Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. , 2009, The New England journal of medicine.

[41]  J. Tschopp,et al.  Risk Factors for Acute Lung Injury After Thoracic Surgery for Lung Cancer , 2003, Anesthesia and analgesia.

[42]  G. Bernard,et al.  Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury* , 2002, Critical care medicine.

[43]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[44]  M. Matthay,et al.  The acute respiratory distress syndrome. , 1996, The New England journal of medicine.

[45]  L. Papazian,et al.  Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients. , 1995, Chest.

[46]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[47]  D. Schuster.  The case for and against fluid restriction and occlusion pressure reduction in adult respiratory distress syndrome. , 1993, New horizons.

[48]  L. Hudson.  Fluid management strategy in acute lung injury. , 1992, The American review of respiratory disease.

[49]  D. Schuster,et al.  Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. , 1992, The American review of respiratory disease.

[50]  D. Schuster,et al.  Fluid balance during pulmonary edema. Is fluid gain a marker or a cause of poor outcome? , 1991, Chest.

[51]  T. Hyers.  ARDS: the therapeutic dilemma. , 1990, Chest.

[52]  H. Humphrey,et al.  Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. , 1990, Chest.

[53]  J. D. Smith,et al.  Fluid balance and the adult respiratory distress syndrome. , 2015, The American review of respiratory disease.

[54]  T L Petty,et al.  Acute respiratory distress in adults. , 1967, Lancet.